Ian Butterwick
Papers
1
Total Citations
2
H-Index
1
About
Ian Butterwick is a researcher whose work sits at the intersection of oncology, medical physics, and advanced radiation therapy. His primary research areas include the integration of novel antimitotic therapies—specifically Tumor Treating Fields (TTFields)—with robotic hypofractionated radiation therapy, as well as the precision targeting challenges that arise when combining these modalities. In his most cited work, "Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy" (2021), Butterwick addresses a critical technical hurdle: how to ensure that TTFields, which disrupt cancer cell division, can be delivered concurrently with high-dose radiation without compromising targeting accuracy. This contribution is particularly significant as TTFields were first proven effective for glioblastoma and are now being trialed for extracranial cancers. While his citation count is currently modest (2 citations for this paper), the work represents an early and important step in a rapidly evolving field, highlighting Butterwick’s forward-looking approach to multimodal cancer treatment. His research is especially relevant for students and researchers interested in the engineering and physics challenges of next-generation cancer therapies.
Research Focus
Key Achievements
Top Papers
- 1